Focal PSMA-Positive Pleural Lesion in a Patient With Stage II Prostate Carcinoma

Clin Nucl Med. 2022 Feb 1;47(2):e170-e171. doi: 10.1097/RLU.0000000000003985.

Abstract

A 70-year-old man with histopathologically proven prostate carcinoma (Gleason, 5 + 5; prostate-specific antigen level, 6.2 μg/mL) was referred for an 18F-PSMA-1007 PET/CT scan. The scan revealed bilateral PSMA uptake in the prostate, representing the primary tumor, but no evidence of PSMA-positive lymph nodes. However, a left-sided ventral pleural thickening showed focal PSMA uptake. Lesion biopsy showed no signs of malignancy, and prostatectomy was performed. The 1-year follow-up CT thorax showed growth of approximately 20% of the pleural lesion. Subsequently, video-assisted thoracic surgery of the lesion was performed. Histopathology showed a solitary fibrous tumor, a rare mesenchymal tumor.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Carcinoma*
  • Edetic Acid
  • Gallium Radioisotopes
  • Humans
  • Male
  • Oligopeptides
  • Positron Emission Tomography Computed Tomography
  • Prostate
  • Prostatectomy
  • Prostatic Neoplasms* / surgery

Substances

  • Gallium Radioisotopes
  • Oligopeptides
  • Edetic Acid